Algenis

30/07/2017

Expertise in the R&D of natural sodium channel blocker molecules derived from microalgae, with multiple potential therapeutic indications. The molecule is small, allowing topical applications, with reversible effect, and no damage to living tissues. Strong IP portfolio with granted patents (14 countries).
www.algenis.com

Esto es un sidebar...

Recent Comments

    Archives

    Categories

    • No categories